Epigenetic Regulation of Cancer Stem Cells by the Aryl Hydrocarbon Receptor Pathway
<p dir="ltr">Compelling evidence has demonstrated that tumor bulk comprises distinctive subset of cells generally referred as cancer stem cells (CSCs) that have been proposed as a strong sustainer and promoter of tumorigenesis and therapeutic resistance. These distinguished propertie...
محفوظ في:
| المؤلف الرئيسي: | Sabah Akhtar (5809925) (author) |
|---|---|
| مؤلفون آخرون: | Shireen Hourani (8879702) (author), Lubna Therachiyil (4246156) (author), Abdullah Al-Dhfyan (4260961) (author), Abdelali Agouni (181926) (author), Asad Zeidan (8879705) (author), Shahab Uddin (154400) (author), Hesham M. Korashy (1474849) (author) |
| منشور في: |
2022
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Epigenetic Regulations of Cancer Stem Cells by the Aryl Hydrocarbon Receptor Pathway
حسب: Sabah, Akhtar
منشور في: (2020) -
Regulation of the aryl hydrocarbon receptor in cancer and cancer stem cells of gynecological malignancies: An update on signaling pathways
حسب: Lubna Therachiyil (4246156)
منشور في: (2022) -
Unlocking the secrets: exploring the influence of the aryl hydrocarbon receptor and microbiome on cancer development
حسب: Menatallah Rayan (14151360)
منشور في: (2024) -
Metformin attenuates V-domain Ig suppressor of T-cell activation through the aryl hydrocarbon receptor pathway in Melanoma: In Vivo and In Vitro Studies
حسب: Fawaz E., Alanazi
منشور في: (2021) -
Crosstalk between aryl hydrocarbon receptor (AhR) and BCL-2 pathways suggests the use of AhR antagonist to maintain normal differentiation state of mammary epithelial cells during BCL-2 inhibition therapy
حسب: Abdullah, Al-Dhfyan
منشور في: (2022)